5Mu L,Feng SS.A novel controlled release formulation for the anticancer drug paclitaxel:PLGA nanoparticles containing vitamin E TPGS[J].J Controlled Release,2006,86(1):33.
6Kaumann M,Hortobagyi GN,Goldhirsch A,et al.Recommendations from an international expert panel on the use of neoadjuvant systemic treatment of operable breast cancer:an update[J].J Clin Oncol,2006,24(12):1940-1949.
5Blum JL, Dieras V, Lo Ruso P M, et al. Multicenter phase 11 study of capecitaline in taxane-pretreated metastatic breast carcinoma patients[J]. Cancer, 2001, 92:1759-1768.
6Michela Di Michelea,Simone Marconea,Lucia Cicchillitti,e al.Glycoproteomics of paclitaxel resistance in human epithelial ovarian cancer cell lines:Towards the identification of putative biomarkers[J].Journal of Proteomics,2010,73(5):879-898.
7Rong Liua,Denis M.Gilmorea,Kimberly Ann V.Zubris,e al.Prevention of nodal metastases in breast cancer following the lymphatic migration of paclitaxel-loaded expansile nanopartic[J].Biomaterials,2013,34(7):1810-1819.
8Kevin J.Volk,Susan E.Hill,Edward H.Kerns,et al.Profiling degradants of paclitaxel using liquid chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry substructural techniques[J].Journal of Chromatography B,1997,696:99-115.
